Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Comprehensive Landscape of Active Deubiquitinating Enzymes Profiled by Advanced Chemoproteomics.

Pinto-Fernández A, Davis S, Schofield AB, Scott HC, Zhang P, Salah E, Mathea S, Charles PD, Damianou A, Bond G, Fischer R, Kessler BM.

Front Chem. 2019 Aug 29;7:592. doi: 10.3389/fchem.2019.00592. eCollection 2019.

2.

Divergent allocation of sperm and the seminal proteome along a competition gradient in Drosophila melanogaster.

Hopkins BR, Sepil I, Thézénas ML, Craig JF, Miller T, Charles PD, Fischer R, Kessler BM, Bretman A, Pizzari T, Wigby S.

Proc Natl Acad Sci U S A. 2019 Sep 3;116(36):17925-17933. doi: 10.1073/pnas.1906149116. Epub 2019 Aug 20.

3.

Deacetylation Inhibition Reverses PABPN1-Dependent Muscle Wasting.

Olie CS, Riaz M, Konietzny R, Charles PD, Pinto-Fernandez A, Kiełbasa SM, Aartsma-Rus A, Goeman JJ, Kessler BM, Raz V.

iScience. 2019 Feb 22;12:318-332. doi: 10.1016/j.isci.2019.01.024. Epub 2019 Jan 22.

4.

Integrated Physiological and Biochemical Assessments for the Prediction of Growth of Abdominal Aortic Aneurysms in Humans.

Lee R, Charles PD, Lapolla P, Cassimjee I, Huang H, Kessler B, Fischer R, Handa A; Oxford Abdominal Aortic Aneurysm Study, the Oxford Regional Vascular Services.

Ann Surg. 2019 Jul;270(1):e1-e3. doi: 10.1097/SLA.0000000000003154. No abstract available.

PMID:
30601258
5.

UFLC-Derived CSF Extracellular Vesicle Origin and Proteome.

Thompson AG, Gray E, Mager I, Fischer R, Thézénas ML, Charles PD, Talbot K, El Andaloussi S, Kessler BM, Wood M, Turner MR.

Proteomics. 2018 Dec;18(24):e1800257. doi: 10.1002/pmic.201800257. Epub 2018 Dec 10.

PMID:
30411858
6.

Quantitative Proteomics Identification of Seminal Fluid Proteins in Male Drosophila melanogaster.

Sepil I, Hopkins BR, Dean R, Thézénas ML, Charles PD, Konietzny R, Fischer R, Kessler BM, Wigby S.

Mol Cell Proteomics. 2019 Mar 15;18(Suppl 1):S46-S58. doi: 10.1074/mcp.RA118.000831. Epub 2018 Oct 4.

7.

Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis.

Psallidas I, Kanellakis NI, Gerry S, Thézénas ML, Charles PD, Samsonova A, Schiller HB, Fischer R, Asciak R, Hallifax RJ, Mercer R, Dobson M, Dong T, Pavord ID, Collins GS, Kessler BM, Pass HI, Maskell N, Stathopoulos GT, Rahman NM.

Lancet Oncol. 2018 Jul;19(7):930-939. doi: 10.1016/S1470-2045(18)30294-8. Epub 2018 Jun 13.

PMID:
29908990
8.

Proteo-metabolomics reveals compensation between ischemic and non-injured contralateral kidneys after reperfusion.

Huang H, van Dullemen LFA, Akhtar MZ, Faro ML, Yu Z, Valli A, Dona A, Thézénas ML, Charles PD, Fischer R, Kaisar M, Leuvenink HGD, Ploeg RJ, Kessler BM.

Sci Rep. 2018 Jun 4;8(1):8539. doi: 10.1038/s41598-018-26804-8.

9.

Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis.

Thompson AG, Gray E, Thézénas ML, Charles PD, Evetts S, Hu MT, Talbot K, Fischer R, Kessler BM, Turner MR.

Ann Neurol. 2018 Feb;83(2):258-268. doi: 10.1002/ana.25143. Epub 2018 Feb 9.

PMID:
29331073
10.

Perturbed cholesterol and vesicular trafficking associated with dengue blocking in Wolbachia-infected Aedes aegypti cells.

Geoghegan V, Stainton K, Rainey SM, Ant TH, Dowle AA, Larson T, Hester S, Charles PD, Thomas B, Sinkins SP.

Nat Commun. 2017 Sep 13;8(1):526. doi: 10.1038/s41467-017-00610-8.

11.

A novel workflow combining plaque imaging, plaque and plasma proteomics identifies biomarkers of human coronary atherosclerotic plaque disruption.

Lee R, Fischer R, Charles PD, Adlam D, Valli A, Di Gleria K, Kharbanda RK, Choudhury RP, Antoniades C, Kessler BM, Channon KM.

Clin Proteomics. 2017 Jun 19;14:22. doi: 10.1186/s12014-017-9157-x. eCollection 2017.

12.

Expanding Proteome Coverage with CHarge Ordered Parallel Ion aNalysis (CHOPIN) Combined with Broad Specificity Proteolysis.

Davis S, Charles PD, He L, Mowlds P, Kessler BM, Fischer R.

J Proteome Res. 2017 Mar 3;16(3):1288-1299. doi: 10.1021/acs.jproteome.6b00915. Epub 2017 Feb 22.

13.

Optimizing 2D gas chromatography mass spectrometry for robust tissue, serum and urine metabolite profiling.

Yu Z, Huang H, Reim A, Charles PD, Northage A, Jackson D, Parry I, Kessler BM.

Talanta. 2017 Apr 1;165:685-691. doi: 10.1016/j.talanta.2017.01.003. Epub 2017 Jan 7.

14.

Subthalamic Nucleus Deep Brain Stimulation Alters Prefrontal Correlates of Emotion Induction.

Bick SK, Folley BS, Mayer JS, Park S, Charles PD, Camalier CR, Pallavaram S, Konrad PE, Neimat JS.

Neuromodulation. 2017 Apr;20(3):233-237. doi: 10.1111/ner.12537. Epub 2016 Oct 12.

15.

Plasma degradome affected by variable storage of human blood.

Kaisar M, van Dullemen LFA, Thézénas ML, Zeeshan Akhtar M, Huang H, Rendel S, Charles PD, Fischer R, Ploeg RJ, Kessler BM.

Clin Proteomics. 2016 Sep 26;13:26. doi: 10.1186/s12014-016-9126-9. eCollection 2016.

16.

Osteogenic potential of laser modified and conditioned titanium zirconium surfaces.

Charles PD, Anandapandian PA, Samuel S.

J Indian Prosthodont Soc. 2016 Jul-Sep;16(3):253-8. doi: 10.4103/0972-4052.186403.

17.

Plasma Biomarker Profile Alterations during Variable Blood Storage.

Kaisar M, van Dullemen LF, Thézénas ML, Charles PD, Ploeg RJ, Kessler BM.

Clin Chem. 2016 Sep;62(9):1272-4. doi: 10.1373/clinchem.2016.257246. Epub 2016 Jul 20. No abstract available.

18.

Integrative Phosphoproteomics Links IL-23R Signaling with Metabolic Adaptation in Lymphocytes.

Lochmatter C, Fischer R, Charles PD, Yu Z, Powrie F, Kessler BM.

Sci Rep. 2016 Apr 15;6:24491. doi: 10.1038/srep24491.

19.

Neck Pain and Cervical Dystonia: Treatment Outcomes from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy).

Charles PD, Manack Adams A, Davis T, Bradley K, Schwartz M, Brin MF, Patel AT.

Pain Pract. 2016 Nov;16(8):1073-1082. doi: 10.1111/papr.12408. Epub 2016 Feb 23.

PMID:
26910788
20.

Antibacterial efficacy and effect of Morinda citrifolia L. mixed with irreversible hydrocolloid for dental impressions: A randomized controlled trial.

Ahmed AS, Charles PD, Cholan R, Russia M, Surya R, Jailance L.

J Pharm Bioallied Sci. 2015 Aug;7(Suppl 2):S597-9. doi: 10.4103/0975-7406.163562.

21.

Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cells.

Ternette N, Yang H, Partridge T, Llano A, Cedeño S, Fischer R, Charles PD, Dudek NL, Mothe B, Crespo M, Fischer WM, Korber BT, Nielsen M, Borrow P, Purcell AW, Brander C, Dorrell L, Kessler BM, Hanke T.

Eur J Immunol. 2016 Jan;46(1):60-9. doi: 10.1002/eji.201545890. Epub 2015 Nov 4.

22.

Expanding the yeast protein arginine methylome.

Plank M, Fischer R, Geoghegan V, Charles PD, Konietzny R, Acuto O, Pears C, Schofield CJ, Kessler BM.

Proteomics. 2015 Sep;15(18):3232-43. doi: 10.1002/pmic.201500032. Epub 2015 Jul 2.

PMID:
26046779
23.

Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells.

Ternette N, Block PD, Sánchez-Bernabéu Á, Borthwick N, Pappalardo E, Abdul-Jawad S, Ondondo B, Charles PD, Dorrell L, Kessler BM, Hanke T.

J Virol. 2015 Jun;89(11):5760-71. doi: 10.1128/JVI.03627-14. Epub 2015 Mar 25.

24.

Erratum: Conserved and host-specific features of influenza virion architecture.

Hutchinson EC, Charles PD, Hester SS, Thomas B, Trudgian D, Martínez-Alonso M, Fodor E.

Nat Commun. 2015 Feb 17;6:6446. doi: 10.1038/ncomms7446. No abstract available.

PMID:
25687574
25.

Conserved and host-specific features of influenza virion architecture.

Hutchinson EC, Charles PD, Hester SS, Thomas B, Trudgian D, Martínez-Alonso M, Fodor E.

Nat Commun. 2014 Sep 16;5:4816. doi: 10.1038/ncomms5816. Erratum in: Nat Commun. 2015;6:6446.

26.

Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy).

Charles PD, Adler CH, Stacy M, Comella C, Jankovic J, Manack Adams A, Schwartz M, Brin MF.

J Neurol. 2014 Jul;261(7):1309-19. doi: 10.1007/s00415-014-7343-6. Epub 2014 Apr 22.

27.

Human urinary exosomes as innate immune effectors.

Hiemstra TF, Charles PD, Gracia T, Hester SS, Gatto L, Al-Lamki R, Floto RA, Su Y, Skepper JN, Lilley KS, Karet Frankl FE.

J Am Soc Nephrol. 2014 Sep;25(9):2017-27. doi: 10.1681/ASN.2013101066. Epub 2014 Apr 3.

28.

Discharge huddle outfitted with mobile technology improves efficiency of transitioning stroke patients into follow-up care.

Tielbur BR, Rice Cella DE, Currie A, Roach JD, Mattingly B, Boone J, Watwood C, McGauran A, Kirshner HS, Charles PD.

Am J Med Qual. 2015 Jan-Feb;30(1):36-44. doi: 10.1177/1062860613510964. Epub 2013 Dec 6.

PMID:
24316727
29.

Identification of protein biomarkers in human serum using iTRAQ and shotgun mass spectrometry.

Koutroukides TA, Jaros JA, Amess B, Martins-de-Souza D, Guest PC, Rahmoune H, Levin Y, Deery M, Charles PD, Hester S, Groen A, Christoforou A, Howard J, Bond N, Bahn S, Lilley KS.

Methods Mol Biol. 2013;1061:291-307. doi: 10.1007/978-1-62703-589-7_18.

PMID:
23963945
30.

FUS in familial essential tremor - the search for common causes is still on.

Hedera P, Davis TL, Phibbs FT, Charles PD, LeDoux MS.

Parkinsonism Relat Disord. 2013 Sep;19(9):818-20. doi: 10.1016/j.parkreldis.2013.04.009. Epub 2013 May 6.

PMID:
23660545
31.

Surgical targets for dystonic tremor: considerations between the globus pallidus and ventral intermediate thalamic nucleus.

Hedera P, Phibbs FT, Dolhun R, Charles PD, Konrad PE, Neimat JS, Davis TL.

Parkinsonism Relat Disord. 2013 Jul;19(7):684-6. doi: 10.1016/j.parkreldis.2013.03.010. Epub 2013 Apr 20.

PMID:
23611688
32.

Potential subjects' responses to an ethics questionnaire in a phase I study of deep brain stimulation in early Parkinson's disease.

Finder SG, Bliton MJ, Gill CE, Davis TL, Konrad PE, Charles PD.

J Clin Ethics. 2012 Fall;23(3):207-16.

PMID:
23256400
33.

Subthalamic nucleus deep brain stimulation impacts language in early Parkinson's disease.

Phillips L, Litcofsky KA, Pelster M, Gelfand M, Ullman MT, Charles PD.

PLoS One. 2012;7(8):e42829. doi: 10.1371/journal.pone.0042829. Epub 2012 Aug 7.

34.

Participation of microRNA 124-CREB pathway: a parallel memory enhancing mechanism of standardised extract of Bacopa monniera (BESEB CDRI-08).

Preethi J, Singh HK, Charles PD, Rajan KE.

Neurochem Res. 2012 Oct;37(10):2167-77. doi: 10.1007/s11064-012-0840-z. Epub 2012 Jul 27.

PMID:
22837048
35.

Uromodulin exclusion list improves urinary exosomal protein identification.

Hiemstra TF, Charles PD, Hester SS, Karet FE, Lilley KS.

J Biomol Tech. 2011 Dec;22(4):136-45.

36.

Deep brain stimulation in early Parkinson's disease: enrollment experience from a pilot trial.

Charles PD, Dolhun RM, Gill CE, Davis TL, Bliton MJ, Tramontana MG, Salomon RM, Wang L, Hedera P, Phibbs FT, Neimat JS, Konrad PE.

Parkinsonism Relat Disord. 2012 Mar;18(3):268-73. doi: 10.1016/j.parkreldis.2011.11.001. Epub 2011 Nov 21.

37.

Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE).

Jankovic J, Adler CH, Charles PD, Comella C, Stacy M, Schwartz M, Sutch SM, Brin MF, Papapetropoulos S.

BMC Neurol. 2011 Nov 4;11:140. doi: 10.1186/1471-2377-11-140.

38.

Deep brain stimulation for early-stage Parkinson's disease: an illustrative case.

Gill CE, Allen LA, Konrad PE, Davis TL, Bliton MJ, Finder SG, Tramontana MG, Kao CC, Remple MS, Bradenham CH, Charles PD.

Neuromodulation. 2011 Nov-Dec;14(6):515-21; discussion 521-2. doi: 10.1111/j.1525-1403.2011.00391.x. Epub 2011 Sep 21.

39.

Barriers to conducting research with community-dwelling adults who have intellectual disabilities.

Molinari AL, Gill CE, Taylor HM, Charles PD.

Intellect Dev Disabil. 2011 Oct;49(5):392-6. doi: 10.1352/1934-9556-49.5.392. No abstract available.

PMID:
21905834
40.

Deep brain stimulation in early stage Parkinson's disease: operative experience from a prospective randomised clinical trial.

Kahn E, D'Haese PF, Dawant B, Allen L, Kao C, Charles PD, Konrad P.

J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):164-70. doi: 10.1136/jnnp-2011-300008. Epub 2011 Sep 2.

41.

Attenuation of 1-(m-chlorophenyl)-biguanide induced hippocampus-dependent memory impairment by a standardised extract of Bacopa monniera (BESEB CDRI-08).

Rajan KE, Singh HK, Parkavi A, Charles PD.

Neurochem Res. 2011 Nov;36(11):2136-44. doi: 10.1007/s11064-011-0538-7. Epub 2011 Jul 7.

PMID:
21735137
42.

Subthalamic nucleus neuronal firing rate increases with Parkinson's disease progression.

Remple MS, Bradenham CH, Kao CC, Charles PD, Neimat JS, Konrad PE.

Mov Disord. 2011 Aug 1;26(9):1657-62. doi: 10.1002/mds.23708. Epub 2011 May 3.

43.

Bacopa monniera leaf extract up-regulates tryptophan hydroxylase (TPH2) and serotonin transporter (SERT) expression: implications in memory formation.

Charles PD, Ambigapathy G, Geraldine P, Akbarsha MA, Rajan KE.

J Ethnopharmacol. 2011 Mar 8;134(1):55-61. doi: 10.1016/j.jep.2010.11.045. Epub 2010 Dec 1.

PMID:
21129470
44.

Clustering of dystonia in some pedigrees with autosomal dominant essential tremor suggests the existence of a distinct subtype of essential tremor.

Hedera P, Phibbs FT, Fang JY, Cooper MK, Charles PD, Davis TL.

BMC Neurol. 2010 Jul 29;10:66. doi: 10.1186/1471-2377-10-66.

45.

Discordance in informed consent response on the basis of demographic factors: brief report.

Nunez-Wallace KR, Gill CE, Harrison CH, Taylor HM, Charles PD.

Intellect Dev Disabil. 2010 Jun;48(3):175-9. doi: 10.1352/1944-7558-48.3.175.

PMID:
20597728
46.

Nutrient control of eukaryote cell growth: a systems biology study in yeast.

Gutteridge A, Pir P, Castrillo JI, Charles PD, Lilley KS, Oliver SG.

BMC Biol. 2010 May 24;8:68. doi: 10.1186/1741-7007-8-68.

47.

Addressing accuracy and precision issues in iTRAQ quantitation.

Karp NA, Huber W, Sadowski PG, Charles PD, Hester SV, Lilley KS.

Mol Cell Proteomics. 2010 Sep;9(9):1885-97. doi: 10.1074/mcp.M900628-MCP200. Epub 2010 Apr 10.

48.

Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability.

Charles PD, Gill CE, Taylor HM, Putman MS, Blair CR, Roberts AG, Ayers GD, Konrad PE.

Mov Disord. 2010 Mar 15;25(4):466-73. doi: 10.1002/mds.22995.

PMID:
20131401
49.

Proteomic analysis reveals the role of synaptic vesicle cycling in sustaining the suprachiasmatic circadian clock.

Deery MJ, Maywood ES, Chesham JE, Sládek M, Karp NA, Green EW, Charles PD, Reddy AB, Kyriacou CP, Lilley KS, Hastings MH.

Curr Biol. 2009 Dec 15;19(23):2031-6. doi: 10.1016/j.cub.2009.10.024. Epub 2009 Nov 12.

50.

Positive family history of essential tremor influences the motor phenotype of Parkinson's disease.

Hedera P, Fang JY, Phibbs F, Cooper MK, Charles PD, Davis TL.

Mov Disord. 2009 Nov 15;24(15):2285-8. doi: 10.1002/mds.22772.

PMID:
19795470

Supplemental Content

Loading ...
Support Center